Christine Silverstein
Förmögenhet: 738 893 $ per 2026-06-30
Förmögenhet: 738 893 $ per 2026-06-30
Christine Berni Silverstein is currently Chief Financial Officer at Artios Pharma Ltd. since 2024.
Christine is also a member of the National Investor Relations Institute, Women in Bio, Inc., and Project 1972, Inc. Former roles include Managing Director at SCO Financial Group LLC; Director-Investor Relations at Relmada Therapeutics, Inc. from 2014 to 2016; Independent Director at Immedica Pharma US, Inc. from 2023 to 2025; Independent Director at Abeona Therapeutics, Inc. from 2020 to 2026; Chief Financial Officer at Excision BioTherapeutics, Inc. from 2021 to 2024; and Chief Financial Officer at Emendo Biotherapeutics, Inc. from 2020 to 2021.
Education includes undergraduate studies at Peter J.
Tobin College of Business.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-15 | 119 562 ( 0,21 % ) | 738 893 $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services Operates as a association for corporate officers and investors | Företagsledare/Principal | - |
Women in Bio, Inc.
Women in Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a organization to help women entrepreneurs and executives | Företagsledare/Principal | - |
Project 1972, Inc.
Project 1972, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a women’s leadership network that promotes members to amplify their influence, access tools and connections | Företagsledare/Principal | - |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for cancer treatment | Finansdirektör/CFO | 2024-02-01 |
| Företag | Position | Slut |
|---|---|---|
| ABEONA THERAPEUTICS INC. | Finansdirektör/CFO | 2020-03-31 |
| MARINUS PHARMACEUTICALS, INC. | Direktör/Styrelseledamot | 2025-02-11 |
Excision BioTherapeutics, Inc.
Excision BioTherapeutics, Inc. BiotechnologyHealth Technology Develops gene editing therapeutics | Finansdirektör/CFO | 2024-01-01 |
Emendo Biotherapeutics, Inc.
Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Operates genome editing company that develops genetic medicines and cell therapies for severe diseases | Finansdirektör/CFO | 2021-01-01 |
| RELMADA THERAPEUTICS, INC. | Investor Relations Kontakt | 2016-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 11 |
|---|---|
Abeona Therapeutics, Inc.
Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Marinus Pharmaceuticals, Inc.
Marinus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for rare genetic epilepsies and other seizure disorders | Health Technology |
SCO Financial Group LLC
SCO Financial Group LLC Investment Banks/BrokersFinance Operates a full service merchant bank | Finance |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services Operates as a association for corporate officers and investors | Commercial Services |
Women in Bio, Inc.
Women in Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a organization to help women entrepreneurs and executives | Commercial Services |
Relmada Therapeutics, Inc.
Relmada Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products for the treatment of depression and other central nervous system diseases | Health Technology |
Peter J. Tobin College of Business
Peter J. Tobin College of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for cancer treatment | Health Technology |
Excision BioTherapeutics, Inc.
Excision BioTherapeutics, Inc. BiotechnologyHealth Technology Develops gene editing therapeutics | Health Technology |
Project 1972, Inc.
Project 1972, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a women’s leadership network that promotes members to amplify their influence, access tools and connections | Commercial Services |
Emendo Biotherapeutics, Inc.
Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Operates genome editing company that develops genetic medicines and cell therapies for severe diseases | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån